Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Formula30A Full Spectrum CBD
- Development stage
- Preclinical
- Lead developer
- Formula30A
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Formula30A Full Spectrum CBD is a phytocannabinoid-based dietary supplement developed by Formula30A. It is produced using a patented, solvent-free, water-based extraction process to create a full-spectrum hemp extract containing cannabidiol (CBD), other phytocannabinoids, terpenes, and flavonoids, while ensuring THC levels remain below 0.3%. The product is typically formulated with organic coconut oil in vegan capsules or as an oral oil. It is primarily distributed through medical providers for the management of chronic pain, anxiety, and insomnia. As a full-spectrum CBD product, its mechanism of action involves the modulation of the endocannabinoid system and interaction with various non-cannabinoid receptors, such as 5-HT1A and TRPV1, to exert its wellness effects.
- Brand names
- Formula30AFormula-30AFormula 30A
- Other names
- Formula30A Full Spectrum CannabinoidsFormula-30A Full Spectrum CannabinoidsFormula 30A Full Spectrum CannabinoidscannabidiolCBD
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))CNR1 (Cannabinoid receptor 1)GPR55 (G protein-coupled receptor 55)PPARG (Peroxisome proliferator-activated receptor gamma)TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPV2 (Transient receptor potential cation channel subfamily V member 2)TRPV3 (Transient receptor potential vanilloid subtype 3)TRPV4 (Transient receptor potential cation channel subfamily V member 4)
Beyond the preview
Go deeper on Formula30A Full Spectrum CBD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Formula30A Full Spectrum CBD.